Table 1.
Baseline characteristics of all included patients.
| Characteristic | Bladder Cancer (n = 14) | Benign Hematuria (n = 12) | p-Value |
|---|---|---|---|
| Sex, n (%) | 0.054 | ||
| Male | 11 (78.6) | 5 (41.3) | |
| Female | 3 (21.4) | 7 (58.3) | |
| Age, yr, median (IQR) | 70.0 (62.5–79.3) | 58.5 (49.3–70.8) | 0.033 |
| WHO 1973 grade, n (%) | - | ||
| Grade 1 | 2 (14.3) | - | |
| Grade 2 | 7 (50.0) | - | |
| Grade 3 | 5 (35.7) | - | |
| WHO 2004 grade, n (%) | - | ||
| Low-grade | 8 (57.1) | - | |
| High-grade | 6 (42.9) | - | |
| Stage, n (%) | - | ||
| Ta | 9 (64.3) | - | |
| Tis | 1 (7.1) | - | |
| T1 | 2 (14.3) | - | |
| T3b | 2 (14.3) | - | |
| Primary/recurrence, n (%) | - | ||
| Primary | 8 (57.1) | - | |
| Recurrence | 6 (42.9) | - | |
| Number of tumors, n (%) | - | ||
| Solitary | 8 (57.1) | - | |
| Multiple | 6 (42.9) | - | |
| Tumor size, n (%) | - | ||
| <3 cm | 11 (78.6) | - | |
| ≥3 cm | 3 (21.4) | - | |
| CIS, n (%) | - | ||
| No | 12 (85.7) | - | |
| Yes | 2 (14.3) | - |
Abbreviations: yr = year; IQR = interquartile range; WHO = World Health Organization; CIS = carcinoma in situ.